Repetitive Transcranial Magnetic Stimulation (rtms) Fails to Improve Cognition in Patients with Parkinson's Disease: a Meta-analysis of Randomized Controlled Trials.

Pei Kun He,Li Min Wang,Jia Ning Chen,Yu Hu Zhang,Yu Yuan Gao,Qi Huan Xu,Yi Hui Qiu,Hui Min Cai,You Li,Zhi Heng Huang,Shu Jun Feng,Jie Hao Zhao,Gui Xian Ma,Kun Nie,Li Juan Wang

DOI: https://doi.org/10.1080/00207454.2020.1809394

2020-01-01

International Journal of Neuroscience

Abstract:Background Cognitive decline is one of the greatest concerns for patients with Parkinson's disease (PD) and their care partners. Repetitive transcranial magnetic stimulation (rTMS) is a nonpharmacological treatment option used to improve cognitive function in PD, but its efficacy is unclear. We performed a meta-analysis to determine whether rTMS improves cognition in PD patients. Methods Eligibility criteria (PICOS) were as follows: (1) 'P': The patients participating were diagnosed with idiopathic PD; (2) 'I': Intervention using rTMS; (3) 'C': Sham stimulation as control; (4) 'O': The outcome of the study included cognitive evaluations; (5) 'S': The study adopted randomized controlled design. The standardized mean difference (SMD) of change of score was applied to measure efficacy, and we used Version 2 of the Cochrane tool to assess risk of bias. Results Twelve studies met the inclusion criteria. Compared with sham-controlled group, the pooled result showed a non-significant short-term effect of rTMS on global cognition (SMD: -0.15, 95% CI: -0.59 to 0.29, I (2) = 36.7%), executive function (SMD: 0.03, 95% CI: -0.21 to 0.26, I (2) = 0.0%), and attention and working memory (SMD: 0.05, 95% CI: -0.25 to 0.35, I (2) = 0.0%). Long-term outcomes were either shown to be statistically nonsignificant. Conclusions Based on a limited number of studies, rTMS fails to improve cognition in PD. We call for additional high-quality randomized controlled trials with adequate sample sizes to determine the efficacy of rTMS.